Cytovation Strengthens its Board of Directors for Next Phase

/PRNewswire/ -- Cytovation ASA, a clinical stage immune-oncology company focused on the development of CyPep-1, its first-in-class targeted tumor membrane...

Related Keywords

Norway , Oslo , Ireland , United Kingdom , Switzerland , Haukeland , Hordaland , Norwegian , Hilde Hukkelberg , Kongstun Arnesen , Federico Grego , Livh Dyrnes , Frazer Hall Mark , Kjell Bernstr , Stein Christian Mohn , Prnewswire Cytovation , Haukeland University Hospital , Boehringer Ingelheim , University Of Bergen , University Of Bergen Norway , Oslo Stock Exchange , Mohn Drilling , Hubro Therapeutics , Oslo Cancer , University Director , Innovation Norway , Norwegian Government , Klaveness Combination Carriers , Oslo Stock , Christian Mohn , Chief Business Officer , Mark Swallow , George Underwood , Cytovation As ,